Dewi

Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status

Dewi 2025-09-03

TOKYO and CAMBRIDGE, Mass., Sept. 3, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai has initiated the rolling submission of the Supplemental Biologics License […]

Fujitsu, 1Finity and Arrcus sign strategic partnership agreement to deliver innovative network solutions for AI infrastructure

Dewi 2025-09-03

Kawasaki, Japan and San Jose, USA, September 3, 2025 – (JCN Newswire via SeaPRwire.com) – Fujitsu Limited, 1Finity Inc., a Fujitsu company and leading provider of global network solutions, and Arrcus Inc., the hyperscale networking software company and a leader in core, edge, and multi-cloud routing and switching infrastructure, today […]

Mitsubishi Corporation Invests in Commonwealth Fusion Systems, a US Fusion Energy Start-up from MIT

Dewi 2025-09-02

Massachusetts, USA, September 2, 2025 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Corporation (“MC”) is pleased to announce its participation in a third-party allotment of shares by Commonwealth Fusion Systems LLC (Headquarter: Massachusetts, USA, Representative: Bob Mumgaard, “CFS”), a fusion energy start-up originating from MIT *1. This investment was made in […]

Hitachi has been certified as a Gold Partner of Scaled Agile, Inc., the provider of the large-scale agile framework “SAFe(R)”

Dewi 2025-09-02

TOKYO, September 2, 2025 – (JCN Newswire via SeaPRwire.com) – Hitachi, Ltd. (TSE:6501, “Hitachi”) has been certified as a Gold Partner*1 of Scaled Agile, Inc. (“SAI”), the provider of SAFe®, the world’s most trusted system for business agility. SAFe is a management framework that supports organizational transformation and business agility, […]

DENSO Signs Agreement to Transfer Part of Its Ceramic Product Business

Dewi 2025-09-01

KARIYA, JAPAN, September 1, 2025 – (JCN Newswire via SeaPRwire.com) – DENSO CORPORATION (hereinafter “DENSO”) today announced that its Board of Directors has resolved to transfer its Spark Plug and Exhaust Gas Sensor business (Oxygen Sensor and Air-Fuel Ratio Sensor), to Niterra Co., Ltd (hereinafter “Niterra”). The two parties reached […]

FDA Approves LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

Dewi 2025-09-01

TOKYO and CAMBRIDGE, MA, August 30, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the U.S. Food and Drug Administration (FDA) has approved the Biologics License […]

TANAKA Memorial Foundation to Offer Precious Metals Research Grants of Up to 10 Million Yen (from a Grant Pool of 20 Million Yen) – Applications for Research Projects Open on September 1

Dewi 2025-09-01

TOKYO, Sept 1, 2025 – (JCN Newswire via SeaPRwire.com) – TANAKA Memorial Foundation (Representative Director: Hideya Okamoto) has announced that it will be accept applications for research themes for FY2025 Precious Metals Research Grants from September 1 to November 28, 2025. This grant program aims to contribute to the development of […]

Ministry Of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anticancer Agent Tazemetostat for Unresectable INI1-Negative Epithelioid Sarcoma

Dewi 2025-08-29

TOKYO, August 29, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has received orphan drug designation for anticancer agent the EZH2*1 inhibitor tazemetostat hydrobromide (generic name, product name “Tazverik® Tablets 200 mg”, “tazemetostat”) for unresectable INI1*2-negative epithelioid sarcoma […]

Hitachi Energy acquires remaining stake of eks Energy, reinforcing leadership in power conversion systems for energy storage

Dewi 2025-08-29

Completion of strategic acquisition affirms Hitachi Energy’s position as a market and technology leader in advancing energy storage innovation – a cornerstone of secure energy transitions Power electronics with advanced digital capabilities are critical to ensure reliability and stability of the electric grid Zurich, Switzerland, August 28, 2025 – (JCN […]